f Aptamers for Brain Tumors: A Therapeutic Agent for Effectively Crossing the Blood-Brain Barrier

References

1. SungH. FerlayJ. SiegelR.L. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202171320924910.3322/caac.21660 33538338
   [Google Scholar]
2. ChenL. ZengD. XuN. Blood–brain barrier- and blood–brain tumor barrier-penetrating peptide-derived targeted therapeutics for glioma and malignant tumor brain metastases.ACS Appl. Mater. Interfaces20191145418894189710.1021/acsami.9b14046 31615203
   [Google Scholar]
3. ZhangL. LiuY. HuangH. Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors.Adv. Drug Deliv. Rev.202219011453610.1016/j.addr.2022.114536 36108792
   [Google Scholar]
4. GabathulerR. Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases.Neurobiol. Dis.2010371485710.1016/j.nbd.2009.07.028 19664710
   [Google Scholar]
5. AmeroP. KhatuaS. Rodriguez-AguayoC. Lopez-BeresteinG. Aptamers: Novel therapeutics and potential role in neuro-oncology.Cancers20201210288910.3390/cancers12102889 33050158
   [Google Scholar]
6. HaysE. DuanW. ShigdarS. Aptamers and glioblastoma: Their potential use for imaging and therapeutic applications.Int. J. Mol. Sci.20171812257610.3390/ijms18122576 29189740
   [Google Scholar]
7. AffinitoA. QuintavalleC. EspositoC.L. Targeting ephrin receptor tyrosine kinase A2 with a selective aptamer for glioblastoma stem cells.Mol. Ther. Nucleic Acids20202017618510.1016/j.omtn.2020.02.005 32169805
   [Google Scholar]
8. WangT. PhilippovichS. MaoJ. VeeduR.N. Effcient epidermal growth factor receptor targeting oligonucleotide as a potential molecule for targeted cancer therapy.Int. J. Mol. Sci.20192019470010.3390/ijms20194700 31546749
   [Google Scholar]
9. Karahmet SherE. AlebićM. Marković BorasM. Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments.Int. J. Pharm.202466012434510.1016/j.ijpharm.2024.124345 38885775
   [Google Scholar]
10. MatićA. SherE.K. FarhatE.K. SherF. Nanostructured materials for drug delivery and tissue engineering applications.Mol. Biotechnol.2023Epub ahead of print10.1007/s12033‑023‑00784‑1 37347435
    [Google Scholar]
11. PengL. LiangY. ZhongX. Aptamer-conjugated gold nanoparticles targeting epidermal growth factor receptor variant III for the treatment of glioblastoma.Int. J. Nanomedicine2020151363137210.2147/IJN.S238206 32184591
    [Google Scholar]
12. MacdonaldJ. HenriJ. GoodmanL. XiangD. DuanW. ShigdarS. Development of a bifunctional aptamer targeting the transferrin receptor and epithelial cell adhesion molecule (EpCAM) for the treatment of brain cancer metastases.ACS Chem. Neurosci.20178477778410.1021/acschemneuro.6b00369 28010059
    [Google Scholar]
13. SherF. BoškailoE. SmječaninN. NemțanuM.R. SherE.K. LimaE.C. Magnetic multifunctional nanomaterials for enhanced transverse chemical and bioanalytical applications: A review.Trends Analyt. Chem.202417311762210.1016/j.trac.2024.117622
    [Google Scholar]
14. FuW. YouC. MaL. Enhanced efficacy of temozolomide loaded by a tetrahedral framework dna nanoparticle in the therapy for glioblastoma.ACS Appl. Mater. Interfaces20191143395253953310.1021/acsami.9b13829 31601097
    [Google Scholar]